Finance

Lists
6BG:FRA
Lytix Biopharma AS
€0.76
+4.40%
(+0.032) 1D
Sep 3, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6BG...
Open
€0.76
High
€0.76
Low
€0.76
Avg. vol.
0.00
Volume
0.00
52-wk high
€1.02
52-wk low
€0.57
No. of employees
14
Open
€0.76
High
€0.76
Low
€0.76
Avg. vol.
0.00
Volume
0.00
52-wk high
€1.02
52-wk low
€0.57
No. of employees
14
About Lytix Biopharma AS
CEOØystein Rekdal
Employees14
Founded2003
Headquarters-
SectorBiotechnology
Previous reportsAll values in NOK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NOK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.82M
5.90M
14.24M
15.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.44M
9.53M
6.32M
5.64M
Operating expense
24.26M
21.16M
26.80M
26.83M
Total operating expenses
24.26M
21.16M
26.80M
26.83M
Operating income
-24.26M
-21.16M
-26.80M
-26.83M
Other non operating income
1.00K
1.68M
-
9.00K
EBT including unusual items
-23.34M
-18.66M
-25.94M
-26.67M
EBT excluding unusual items
-23.34M
-18.66M
-25.94M
-26.67M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
3.74M
5.48M
5.99M
5.04M
Net income
-23.34M
-18.66M
-25.94M
-26.67M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
921.00K
1.09M
858.00K
250.00K
Interest expense
-
-94.00K
-
-38.00K
Net interest expenses
921.00K
996.00K
858.00K
212.00K
Depreciation and amortization charges
252.00K
244.00K
249.00K
249.00K
EBITDA
-24.25M
-21.16M
-26.79M
-26.82M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps